Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SCARNA9 gene

Known as: SCARNA9, mgU2-19/30, small Cajal body-specific RNA 9 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Visible light-responsive tetradecahedral ZnO-SnO2-Zn2SnO4 photocatalysts possessing double Z-scheme mechanism were prepared via a… Expand
2019
2019
CACX is one of the most common cancer affecting women world-wide. Here, expression microarray analysis revealed 8 over-expressed… Expand
2018
2018
ABSTRACT Small Cajal body-specific RNAs (scaRNAs) are part of small Cajal body-specific ribonucleoproteins (scaRNPs) that modify… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
Antibodies are extensively used in research, diagnostics, and therapy, and for many applications the antibodies need to be… Expand
2014
2014
In this paper we describe a software system for testing hypothe- ses about near-rings on finite cyclic groups. The system allows… Expand
  • figure 1
  • figure 2
  • table 1
2005
2005
We have comparatively investigated the photophysical properties of a series of meso-meso directly linked orthogonal porphyrin… Expand
2005
2005
  • S. F. Jiwa
  • Tropical Animal Health and Production
  • 2005
  • Corpus ID: 23282592
The Walugurus who inhabit the Morogoro area have not traditionally kept livestock, however in recent years meat goats have been… Expand
2003
2003
Abstract We study strings on orbifolds of AdS×S5 by SU(2) discrete groups in the Penrose limit. We derive the degenerate metrics… Expand
2002
2002
  • J. Nash
  • SPIE ITCom
  • 2002
  • Corpus ID: 56356880
A specialized CAD tool is described that will take a user's high level code description of a non-uniform affinely indexed… Expand
1998
1998
This paper deals with the problem of identifying a hidden Boolean function ö : {0,1} 6 {0,1} from positive and negative examples… Expand
  • table I
  • figure 2
  • table II
  • figure 3
  • figure 4